Search Results 10061-10070 of 37227 for oral

1. Insulin glargine-aglr, recombinant (subcutaneous route) - Side effects & dosage - Mayo Clinic

   You may have to use insulin glargine-aglr in combination with another type of insulin or with a type of oral diabetes medicine to keep your blood sugar under ...

2. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

   ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

3. Testing The Use Of The Combination Of Selumetinib And Olaparib Or Selumetinib Alone Targeted Treatment For RAS Pathway Mutant Recurrent Or Persistent Ovarian And Endometrial Cancers, A ComboMATCH Treatment Trial - Mayo Clinic

   - Patients must be able to swallow and retain oral medications and be without gastrointestinal illnesses that would preclude absorption of selumetinib or ...

4. Physical Therapy Oncologic Residency (Minnesota) - Health Sciences Education

   Residents are licensed physical therapists and receive a stipend and benefits package. Completion and certification. Upon successful completion of the Physical ...

5. Science Saturday: Reengineering the OR, one step at a time - Mayo Clinic News Network

   Living With Cancer: Do you need oral cancer screening? Sharing Mayo Clinic: Diagnosed with stiff-person syndrome. Related Articles. A hand touches a virtual ...

6. Clinical trials - Oncology (Medical)

   Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...

7. Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA) - Mayo Clinic

   contraception (oral contraceptive pills, implants, transdermal patches, vaginal rings or long-acting injections). ii. Women not of childbearing potential ...

8. Robotic surgery - Doctors & Departments - Mayo Clinic

   ... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer. Show more areas of focus for Eric J. Moore, M.D.. Adyr A ...

9. Clinical trials - Oncology (Medical)

   ... oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B-cell Lymphoblastic Leukemia (B LLy) ...

10. Clinical trials - Oncology (Medical)

    ... oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B-cell Lymphoblastic Leukemia (B LLy) ...